Development

From Cultivation to Production

Production Technology

In order to market the BRM capabilities of our EF-2001 as a reliable product, we use an immunity ‘activity evaluation test’ to test it against the anti-cancer pharmaceutical agent OK432(Picibilnil). This ‘activity evaluation test’ is carried out each product shipment lot, with strict quality standards in place. Only products that have a potency of at least 70% of that of the pharmaceutical product are marketed.

R&D Center

Our Main Research targets divided into three main areas: EF-2001 Culture Condition, Bioactivity and Product Development.


We continuously study EF-2001 culture condition to cultivate the best quality seed cell and also to preserve its BRM substances. BeRM’s Bioactivity Research focuses on EF-2001’s biological function in human body. Quality control (BeRM Immune activation Test) is held on each stage of production to produce superior quality raw material for Product Development section to utilize our technology.

This lab’s research was financially supported by the Ministry of Trade, industry, and Energy(MOTEI), Korea, under the “Regional Specialized industry Development Program” supervised by the Korea institute for Advancement of Technology(KIAT)

Quality Control

Immune Activation Test

In order to market the BRM capabilities of our EF-2001 as a reliable product, we use an immunity ‘activity evaluation test’ to test it against the anti-cancer pharmaceutical agent OK432(Picibilnil). This ‘activity evaluation test’ is carried out each product shipment lot, with strict quality standards in place. Only products that have a potency of at least 70% of that of the pharmaceutical product are marketed.